SpecificIT | SpecificiT Pharma Inc.
home,page-template,page-template-full_width,page-template-full_width-php,page,page-id-2,,qode-title-hidden,qode-child-theme-ver-,qode-theme-ver-10.0,wpb-js-composer js-comp-ver-4.12,vc_responsive

About SpecificiT Pharma Inc.

SpecificiT Pharma Inc., a privately held biopharmaceutical company focused on developing innovative personalized cancer immunotherapies.

SpecificiT is developing cellular therapies for hematological cancers which to date, cannot be treated with chimeric antigen receptor modified T cells (CAR-T) therapies.

SpecificiT’s unique approach is centered on the use of Minor Histocompatability Antigens (“MiHAs”) which enable donor T-cells to be safely directed to eliminate cancer cells in a patient.